AcquisitionOther
Graf Acquisition Corp. IV acquired NKGen Biotech, Inc. to September 25, 2023 THE WOODLANDS, Texas, September 22, 2023
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Graf Acquisition Corp. IV -> NKGen Biotech, Inc. to September 25, 2023 THE WOODLANDS, Texas, September 22, 2023 · $50 million
The Company also filed a supplement (the "Supplement") to its definitive proxy statement/prospectus relating to the Special Meeting (the “Definitive Proxy Statement/Prospectus”) that was initially filed on August 14, 2023, with the Securities and Exchange Comm
Open source record (SEC) ↗